Endo International Plc
(NASDAQ : ENDP)

( )
ENDP After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corp. Plc 0.42%4.801.6%$106.58m
PRGOPerrigo Co. Plc 7.17%47.546.8%$86.50m
VRXValeant Pharmaceuticals International, Inc. 9.77%14.6114.1%$85.97m
JAZZJazz Pharmaceuticals Plc 7.10%105.772.3%$83.87m
CTLTCatalent, Inc. 7.05%52.382.2%$74.82m
ICLRICON plc 10.86%145.074.2%$73.26m
HZNPHorizon Therapeutics Plc 1.88%31.966.5%$72.76m
UTHRUnited Therapeutics Corp. 3.26%95.7614.3%$71.70m
AXSMAxsome Therapeutics, Inc. -2.67%53.551.9%$65.19m
GWPHGW Pharmaceuticals Plc 5.84%86.586.2%$55.37m
ICPTIntercept Pharmaceuticals, Inc. 6.98%62.8516.8%$42.06m
SAGESAGE Therapeutics, Inc. 9.33%28.378.6%$39.86m
PBHPrestige Consumer Healthcare, Inc. 4.26%39.154.0%$35.65m
PCRXPacira Biosciences, Inc. 3.90%32.0010.4%$30.20m
MYOKMyoKardia, Inc. 3.62%48.052.1%$26.76m

Company Profile

Endo International Plc operates as a pharmaceutical company. It focuses on developing, manufacturing, and distributing of branded and generic pharmaceutical products. The firm operates through the following segments: U.S. Branded-Specialty & Established Pharmaceuticals, U.S. Branded-Sterile Injectables, U.S. Generic Pharmaceuticals and International Pharmaceuticals. The U.S. Branded-Specialty & Established Pharmaceuticals segment offers prescription products to treat and manage conditions in urology, urologic oncology, endocrinology, pain and orthopedics. The U.S. Branded-Sterile Injectables segment consists primarily of branded sterile injectable products such as VASOSTRICT, ADRENALIN and APLISOL, among others, and certain generic sterile injectable products, including ertapenem for injection and ephedrine sulfate injection, among others. The U.S. Generic Pharmaceuticals segment consists of a differentiated product portfolio including solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmics and sprays and includes products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health and cardiovascular disease markets, among others. The International Pharmaceuticals segment includes a variety of pharmaceutical products for the Canadian, Latin American, South African, and world markets. The company was founded in 1997 and is headquartered Dublin, Ireland.